The mechanical properties depend primarily on the cytoskeleton, and it is expected that the decreased value of cell elasticity (Figure 7c–e) caused by Rac1 inhibition is associated with the disruption of cytoskeleton organization inside GBM cells (Figures S3 and S4). Here, RAC1 is linked to glioblastoma.